Vasoactive intestinal peptide stimulates immunoglobulin production and growth of human B cells

Clinical & Experimental Immunology

Volumn 87, Issue 3, 1992, Pages 504-508

  ISHIOKA, C ^a   YOSHIDA, A ^a   KIMATA, H ^a   MIKAWA, H ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

B cell responses; isotype specific IgA production; vasoactive intestinal peptide

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; B LYMPHOCYTE; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; PRIORITY JOURNAL; TONSIL;

B-LYMPHOCYTES; CELL DIVISION; DNA; HUMAN; IMMUNOGLOBULIN A; RECEPTORS, GASTROINTESTINAL HORMONE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; THYMIDINE; TUMOR CELLS, CULTURED; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0026577956     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1992.tb03027.x     Document Type: Article

References (37)

1. Modulation of lymphocyte function by sensory neuropeptides
2. Vasoactive intestinal polypeptide modulation of lymphocytes adenylate cyclase
3. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen
4. Polypeptide with broad biological activity: isolation from the small intestine
5. A porcine brain polypeptide is identical to the vasoactive intestinal polypeptide
6. On the immunocytochemical localization of the vasoactive intestinal polypeptide
7. Distribution and tissue localization of VIP in the central nervous system and in seven peripheral organs
8. Selective localization of vasoactive intestinal peptide and substance P in human eosinophils
9. Vasoactive intestinal polypeptide as a biochemical marker for polymorphonuclear leucocytes
10. Vasoactive intestinal polypeptide as a marker for polymorphonuclear leucocytes
11. Immunoreactivities of vasoactive intestinal peptide (VIP) and glucagon in leucocytes from leucemic patients
12. Vasoactive intestinal polypeptide and somatostalin in leucocytes
13. Vasoactive intestinal polypeptide: Current status
14. Interaction of vasoactive intestinal peptide with mouse lymphocyte: specific binding and the modulation of mitogen responses
15. Selective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells
16. Influence of beta‐endorphin, somatostatin, substance P and vasoactive intestinal peptide on the proliferative response of human peripheral blood T lymphocytes to mercuric chloride
17. The effect of vasoactive intestinal peptide on human natural killer cell function
18. Interaction of vasoactive intestinal peptide with human blood mononuclear cells
19. Specific binding sites for vasoactive intestinal peptide on nonadherent peripheral blood lymphocytes
20. Specific binding of vasoactive intestinal peptide to human circulating mononuclear cells
21. Interaction of vasoactive intestinal peptide with human blood lymphocytes: specific binding and cyclic AMP production
22. High affinity specific binding of vasoactive intestinal peptide to human circulating T celts, B cells and large granular lymphocytes
23. Demonstration of a functional receptor for vasoactive intestinal peptide on Molt 4b T lymphoblasts
24. High‐affinity receptors for vasoactive intestinal peptide on human myeloma cells
25. Identification of high receptors for vasoaclive intestinal peptide on human lymphocytes of B cell lineage
26. Subset of natural killer cells is induced by immune complexes to display Fc receptors for IgE and IgA and demonstrate isotype regulatory function
27. Constitutive production of B cell differentiation factor‐like activity by human T and B cell lines
28. Response patterns of purified myeloma cells to hematopoietic growth factors
29. Isolation of mononuclear cells and granulocytes from human blood
30. Nerve growth factor specially induces human IgG4 production
31. Stimulation of Ig production and growth of human lymphoblastoid B‐cell lines by nerve growth factor
32. The interaction of vasoactive intestinal peptide and secretin with liver membranes
33. Receptors for vasoactive intestinal peptide and secretin on small intestinal epithelial cells
34. Cyclic AMP production in isolated colonic epithelial cells
35. Production of interleukin‐6 by anterior pituitary cells is stimulated by increased intracellular adenosine 3′,5′‐monophosphate and vasoactive intestinal peptide
36. Human natural killer cells produce a late‐acting B‐cell differentiation activity
37. Nerve growth factor inhibits immunoglobulin production by but not proliferation of human plasma cell lines